Dental Surgery: Current Treatments and Future Options

A special issue of Clinics and Practice (ISSN 2039-7283).

Deadline for manuscript submissions: 20 March 2024 | Viewed by 900

Special Issue Editor

Dr. Mustafa Tattan
E-Mail Website
Guest Editor
Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA
Interests: implant dentistry

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to provide a comprehensive overview of the current treatments available in dental surgery, as well as ongoing research and development in this field. The Special Issue will cover a wide range of topics related to dental surgery, including the latest techniques and technologies used in dental procedures, such as dental implants, orthodontic treatments, and oral and maxillofacial surgery. It also discusses the potential future options for dental surgery, including regenerative medicine, stem cell therapy, and precision dentistry. The articles in this Special Issue will present the latest research findings, case studies, and clinical trials related to dental surgery. They will explore the effectiveness of various treatment approaches, their impact on patient outcomes, and the potential complications and risks associated with these procedures. Overall, this Special Issue will provide valuable insights into the current state of dental surgery and will highlight the future directions and potential advancements in this area of the dental field. It is a valuable resource for dental professionals, researchers, and anyone interested in staying up to date with the latest advancements in dental surgery.

Dr. Mustafa Tattan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Clinics and Practice is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • dental surgery
  • guided surgery
  • dental implant therapy
  • orthodontic therapy
  • oral and maxillofacial surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


19 pages, 2245 KiB  
Patient-Reported Outcome Measures of Flapless Corticotomy with Low-Level Laser Therapy in En Masse Retraction of Upper Anterior Teeth: A Three-Arm Randomized Controlled Trial
Clin. Pract. 2023, 13(6), 1501-1519; - 22 Nov 2023
Cited by 1 | Viewed by 637
(1) Background: This study aimed to compare patient-reported outcome measures when accelerating en masse retraction between the piezocision procedure and the subsequent application of low-level laser therapy (FC+LLLT), with the piezocision alone (FC), and in a control group. (2) Methods: A three-arm randomized [...] Read more.
(1) Background: This study aimed to compare patient-reported outcome measures when accelerating en masse retraction between the piezocision procedure and the subsequent application of low-level laser therapy (FC+LLLT), with the piezocision alone (FC), and in a control group. (2) Methods: A three-arm randomized controlled trial (RCT) was conducted involving 60 patients (41 females and 19 males) with Class II division I malocclusion. The en masse retraction was performed using NiTi closed coil springs attached to miniscrews. The LLLT was performed using an 808 nm Ga-Al-As diode laser. Patient responses regarding pain, discomfort, swelling, and chewing difficulties were reported at ten assessment points. (3) Results: The greatest pain levels were observed 24 h after the application of force during the first and third months of retraction. The mean pain, discomfort, swelling, and chewing difficulties were significantly smaller in the control group than in the FC and FC+LLLT groups. High satisfaction levels were reported in all three groups (p < 0.05). (4) Conclusions: The accelerated en masse retraction via piezocision, followed by a small course of LLLT, was accompanied by significantly fewer pain, discomfort, and chewing difficulties than the control group. LLLT is a valuable addition to piezocision, with an improved patient experience. Full article
(This article belongs to the Special Issue Dental Surgery: Current Treatments and Future Options)
Show Figures

Figure 1

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Prostate Adenocarcinoma ISUP Grade Group 1: effect of the label “Cancer” on treatment choice
Authors: E. Bologna; L.C. Licari; G. Franco
Affiliation: Department of Maternal-Child and Urological Sciences, Sapienza University Rome, Policlinico Umberto I Hospital, Rome, Italy
Abstract: Despite American Urological Association (AUA) supports Active Surveillance as "optimal care" for prostatic adenocarcinoma ISUP Grade Group 1 (GG1)  aligned with EAU and NCCN recommendations  over 40% of US men with low-risk prostate cancer choose an immediate or delayed active treatment. In contrast to the histologic or genomic traits, which define GG1 histology, evidences demonstrate that Grade Group 1 tumors experience slow growth and rarely metastasize, setting them apart from aggressive malignancies. In this condition, the patient's understanding of the disease and the physician's grasp of the patient's perspective, emerge as crucial elements for a tailored treatment management. This article's objective is to connect histopathology, clinical implications and treatment decisions in low-risk prostate cancer, in order to evaluate the rationale for and against removing the label "cancer" alongside with ISUP Grade 1.

Back to TopTop